HomeAUROPHARMA • NSE
Aurobindo Pharma Ltd
₹1,090.00
Mar 28, 3:58:31 PM GMT+5:30 · INR · NSE · Disclaimer
StockIN listed securityIN headquartered
Previous close
₹1,070.35
Day range
₹1,064.05 - ₹1,099.25
Year range
₹498.35 - ₹1,177.10
Market cap
638.56B INR
Avg Volume
1.88M
P/E ratio
23.07
Dividend yield
0.41%
Primary exchange
NSE
CDP Climate Change Score
C
Financials
Income Statement
Revenue
Net income
(INR)Dec 2023Y/Y change
Revenue
73.52B14.74%
Operating expense
30.23B5.46%
Net income
9.36B90.59%
Net profit margin
12.7466.10%
Earnings per share
16.0491.41%
EBITDA
14.59B64.96%
Effective tax rate
25.54%
Total assets
Total liabilities
(INR)Dec 2023Y/Y change
Cash and short-term investments
71.49B10.47%
Total assets
Total liabilities
Total equity
281.95B
Shares outstanding
583.72M
Price to book
2.24
Return on assets
Return on capital
8.45%
Net change in cash
(INR)Dec 2023Y/Y change
Net income
9.36B90.59%
Cash from operations
Cash from investing
Cash from financing
Net change in cash
Free cash flow
About
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia
Founded
1986
Employees
23,451
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu